Voyager Therapeutics VYGR
NASDAQ VYGR
$2.67 -0.01 (-0.19%)
At close: Oct 1, 2026 · 4:00 PM EDT

Voyager Therapeutics (VYGR) Cash from Financing Activities (2014 - 2026)

Updated

Voyager Therapeutics (VYGR) recorded Cash from Financing Activities of $2.91 million in Q2 2026, up 466.5% from $513,000 a year earlier but down 12.8% from the prior quarter.

Analysis

Voyager Therapeutics (VYGR) Cash from Financing Activities (2014 - 2026) Analysis & Trends

On a TTM basis, Voyager Therapeutics' Cash from Financing Activities came in at $6.46 million as of Jun 30, 2026, up 446.0% year-over-year; for FY2025, it was $816,000, down 99.3% from FY2024.

  • Annual Cash from Financing Activities has a five-year compound annual growth rate of -23.7% (FY2020 to FY2025).
  • Across earlier years, Cash from Financing Activities came in at $114.02 million in FY2024 (+238.9%), $33.65 million in FY2023, $1.11 million in FY2022 (+81.4%) and $612,000 in FY2021 (-80.7%).
  • Quarterly Cash from Financing Activities has ranged from $12,000 in Q1 2022 to $112.86 million in Q1 2024 over the past five years.
  • On a year-over-year basis, Cash from Financing Activities rose in three of the last seven quarters, with growth averaging 102.3%.
  • Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 507.1% in Q3 2025, against a decline of 99.9% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $3.33 million (Q1 2026), $136,000 (Q4 2025) and $85,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Voyager Therapeutics 164.21 Mn -498.98 Mn - 2.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.91 Mn
Mar 31, 2026 3.33 Mn
Dec 31, 2025 136,000.00
Sep 30, 2025 85,000.00
Jun 30, 2025 513,000.00
Mar 31, 2025 82,000.00
Dec 31, 2024 574,000.00
Sep 30, 2024 14,000.00
Jun 30, 2024 571,000.00
Mar 31, 2024 112.86 Mn
Dec 31, 2023 460,000.00
Sep 30, 2023 331,000.00
Jun 30, 2023 1.55 Mn
Mar 31, 2023 31.31 Mn
Dec 31, 2022 276,000.00
Sep 30, 2022 15,000.00
Jun 30, 2022 807,000.00
Mar 31, 2022 12,000.00
Dec 31, 2021 227,000.00
Jun 30, 2021 357,000.00
API Access

Voyager Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=VYGR&period=max&api_key=YOUR_API_KEY